John Bradley Sorenson - 13 Feb 2025 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Reporting relationship: EVP, Global Operations
Issuer ticker: BSX
Reported as of: 13 Feb 2025
Net transaction value: -$364,304
SEC form: 4
Accepted by SEC: 18 Feb 2025, 17:52:19 UTC
Prior SEC filing: 14 Feb 2025
Next SEC filing: 19 Feb 2025
Source filing: View source filing
Reporting owner signature: /s/ Susan Thompson, Attorney-in-Fact

Key filing fact

John Bradley Sorenson filed Form 4 for BOSTON SCIENTIFIC CORP (BSX) on 18 Feb 2025.

Key facts

This page summarizes John Bradley Sorenson's Form 4 filing for BOSTON SCIENTIFIC CORP (BSX).
12 reported transactions and 5 derivative rows are listed below.
Accepted by SEC: 18 Feb 2025, 17:52.

Change

Previous filing in this sequence was filed on 14 Feb 2025.
Current net transaction value: -$364,304.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BSX transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +2,115
Change %: +8.3%
Price: $0.000000
Shares after: 27,609
Date: 14 Feb 2025
Ownership: Direct
Footnotes: F1

BSX transaction

Common Stock

Tax liability

Transaction value: $102,396
Shares: -965
Change %: -3.5%
Price: $106.11
Shares after: 26,644
Date: 14 Feb 2025
Ownership: Direct

BSX transaction

Common Stock

Sale

Transaction value: $127,678
Shares: -1,201
Change %: -4.5%
Price: $106.31
Shares after: 25,443
Date: 14 Feb 2025
Ownership: Direct
Footnotes: F2

BSX transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +1,273
Change %: +5%
Price: $0.000000
Shares after: 26,716
Date: 16 Feb 2025
Ownership: Direct
Footnotes: F1

BSX transaction

Common Stock

Tax liability

Transaction value: $61,650
Shares: -581
Change %: -2.2%
Price: $106.11
Shares after: 26,135
Date: 16 Feb 2025
Ownership: Direct

BSX transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +1,500
Change %: +5.7%
Price: $0.000000
Shares after: 27,635
Date: 17 Feb 2025
Ownership: Direct
Footnotes: F1

BSX transaction

Common Stock

Tax liability

Transaction value: $72,579
Shares: -684
Change %: -2.5%
Price: $106.11
Shares after: 26,951
Date: 17 Feb 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BSX transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +4,239
Change %
Price: $0.000000
Shares after: 4,239
Date: 13 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,239
Exercise price
Footnotes: F1, F3

BSX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +10,909
Change %
Price: $0.000000
Shares after: 10,909
Date: 13 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,909
Exercise price: $106.14
Footnotes: F4

BSX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -2,115
Change %: -33%
Price: $0.000000
Shares after: 4,230
Date: 14 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,115
Exercise price
Footnotes: F1, F5

BSX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -1,273
Change %: -50%
Price: $0.000000
Shares after: 1,273
Date: 16 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,273
Exercise price
Footnotes: F1, F6

BSX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -1,500
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 17 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,500
Exercise price
Footnotes: F1, F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 7 footnotes

Footnote F1

Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

Footnote F2

The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 9, 2024.

Footnote F3

Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.

Footnote F4

Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.

Footnote F5

Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.

Footnote F6

Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.

Footnote F7

Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.